Federation Des Caisses Desjardins Du Quebec Affimed N.V. Transaction History

Federation Des Caisses Desjardins Du Quebec

$18.9 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Aug 14, 2024	SELL	$1.96 - $3.32 $10,544 - $17,861	-5,380 Closed	0 $0
Q2 2022 Aug 14, 2024	BUY	$2.27 - $4.86 $12,212 - $26,146	5,380 New	5,380 $14.9 Million
Q4 2021 Aug 30, 2024	SELL	$5.37 - $7.07 $48,899 - $64,379	-9,106 Closed	0 $0
Q3 2021 Aug 30, 2024	BUY	$5.54 - $7.51 $50,447 - $68,386	9,106 New	9,106 $56.2 Million
Q1 2021 Aug 30, 2024	SELL	$5.12 - $8.48 $39,889 - $66,067	-7,791 Closed	0 $0
Q4 2020 Aug 30, 2024	SELL	$3.16 - $7.03 $197,793 - $440,028	-62,593 Reduced 88.93%	7,791 $45.4 Million
Q3 2020 Aug 30, 2024	SELL	$3.26 - $4.73 $174,237 - $252,804	-53,447 Reduced 43.16%	70,384 $239 Million
Q4 2019 Aug 30, 2024	BUY	$2.25 - $3.07 $39,368 - $53,715	17,497 Added 16.45%	123,831 $339 Million
Q2 2019 Aug 30, 2024	BUY	$2.6 - $4.21 $276,468 - $447,666	106,334 New	106,334 $305 Million

Others Institutions Holding AFMD

# of Institutions

Shares Held

1.09M

Call Options Held

Put Options Held

Tekla Capital Management LLC

586K
Shares

$2.04 Million
0.01% of portfolio
Act Capital Management, LLC Wayne, PA

309K
Shares

$1.07 Million
0.88% of portfolio
Telemetry Investments, L.L.C. New York, NY

200K
Shares

$696,000
0.39% of portfolio

View Full List

About Affimed N.V.

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $520M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

More about AFMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account